Evidence map›Paper›PMID 24217197›Full record

ArticleLeukemia2014

On the way towards a 'CLL prognostic index': focus on TP53, BIRC3, SF3B1, NOTCH1 and MYD88 in a population-based cohort.

D Cortese, L-A Sutton, N Cahill, K E Smedby, C Geisler, R Gunnarsson, G Juliusson, L Mansouri, R Rosenquist

Open access · bronzeAbstract readLetter
PubMed Publisher
In one paragraph

Article in Leukemia, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed, 1 pooled it
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 1 synthesis or guideline pooled it, 75 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. AGenes · 2024
    Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. The prognostic role of HBV infection in chronic lymphocytic leukemia.Journal of cancer research and clinical oncology · 2018
    Article
  15. Critical molecular pathways in CLL therapy.Molecular medicine (Cambridge, Mass.) · 2018
    Review
  16. Article
  17. Review
  18. Article
  19. The mutational landscape of chronic lymphocytic leukemia and its impact on prognosis and treatment.Hematology. American Society of Hematology. Education Program · 2017
    Review
  20. Clinical utility of recently identified diagnostic, prognostic, and predictive molecular biomarkers in mature B-cell neoplasms.Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc · 2017
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 2 countries.

D CorteseDepartment of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
L-A SuttonDepartment of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
N CahillDepartment of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
K E SmedbyDepartment of Medicine, Clinical Epidemiology Unit, Karolinska Institutet, Stockholm, Sweden.
C GeislerDepartment of Hematology, Leukemia Laboratory, Rigshospitalet, Copenhagen, Denmark.
R GunnarssonDepartment of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
G JuliussonDepartment of Laboratory Medicine, Stem Cell Center, Hematology and Transplantation, Lund University, Lund, Sweden.
L MansouriDepartment of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
R RosenquistDepartment of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
Science for Life Laboratory · SEKarolinska Institutet · SELund University · SERigshospitalet · DKUppsala University · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Baculoviral IAP Repeat-Containing 3 ProteinCohort StudiesHumansInhibitor of Apoptosis ProteinsLeukemia, Lymphocytic, Chronic, B-CellMyeloid Differentiation Factor 88PhosphoproteinsPrognosisReceptor, Notch1Ribonucleoprotein, U2 Small NuclearRNA Splicing FactorsTumor Suppressor Protein p53Ubiquitin-Protein LigasesBaculoviral IAP Repeat-Containing 3 ProteinBIRC3 protein, humanInhibitor of Apoptosis ProteinsMYD88 protein, humanMyeloid Differentiation Factor 88NOTCH1 protein, humanPhosphoproteinsReceptor, Notch1Ribonucleoprotein, U2 Small NuclearRNA Splicing FactorsSF3B1 protein, humanTumor Suppressor Protein p53Ubiquitin-Protein Ligases

Identifiers

PMID24217197
OpenAlexW2005092974

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.